European pharma stocks fall after Trump slaps 100% tariffs on medicine imports

European pharma stocks fall after Trump slaps 100% tariffs on medicine imports


Stocks listed in Europe were broadly higher on Friday, as investors assessed the latest trade policy announcements out of the White House.

The pan-European Stoxx 600 index was up by 0.2% by around 10:00 a.m. London time (5 a.m. ET), with most sectors in positive territory.

The Stoxx Europe 600 Healthcare index saw rocky trade in the morning, oscillating above and below the flatline. It was last seen trading 0.2% lower.

Overnight, President Donald Trump announced that pharmaceutical imports to the U.S. would be hit with 100% tariffs from Oct. 1. Companies who built manufacturing facilities in America would be exempt, Trump said, but only once they started breaking ground on the construction of U.S. plants.

Previously, Trump had threatened to impose tariffs of up to 200% on pharma imports.

Denmark’s Zealand Pharma was last seen down 2.5%, while Novo Nordisk and Finland’s Orion were also trading more than 2% lower on Friday morning.

However, in a note circulated in the wake of Trump’s announcements, JP Morgan strategists downplayed the impact the new tariffs would have on the pharmaceutical sector.

The “potential 100% tariff should largely be avoidable with us based manufacturing buildout,” they said. “And while there remain a number of unknowns on tonight’s announcement … we continue to see a very manageable overall impact from tariffs to our large cap coverage.”

Trump also announced on his Truth Social platform on Thursday night that heavy trucks would be slapped with 25% tariffs from next month.

The European Union’s own trade policies are also in focus, after German newspaper Handelsblatt reported that the bloc was planning to impose tariffs of up to 50% on Chinese steel in the coming weeks.

On Thursday, European stocks closed lower following the Trump administration’s launch of a national security probe into medical device imports, which could pave the way for further tariffs.

Overnight in Asia, pharma stocks notched losses as investors reacted to the looming U.S. tariffs on the sector.

In terms of economic data, Friday will see the release of Spain’s latest inflation print, U.K. mortgage lending figures, and a report on European economic sentiment.



Source

Marvell stock pops 11% as Nvidia takes  billion stake, continuing run of similar bets
World

Marvell stock pops 11% as Nvidia takes $2 billion stake, continuing run of similar bets

Jonathan Raa | Nurphoto | Getty Images Shares of Marvell Technology surged more than 11% after Nvidia announced plans to invest $2 billion in the semiconductor company as companies race to meet ballooning artificial intelligence demand. The deal ties Marvell into Nvidia’s AI ecosystem, making it easier for customers to build on the infrastructure. Both […]

Read More
Trump lashes out at UK and France, telling allies ‘the U.S.A won’t be there to help you anymore’
World

Trump lashes out at UK and France, telling allies ‘the U.S.A won’t be there to help you anymore’

U.S. President Donald Trump speaks during the Future Investment Initiative (FII) Summit in Miami Beach, Florida, on March 27, 2026. Mandel Ngan | AFP | Getty Images President Donald Trump has warned the U.K. and France that the “U.S.A. won’t be there to help you anymore,” as he vented his frustration over the close allies’ […]

Read More
Euro zone inflation smashes through ECB target to 2.5% in March as energy costs soar
World

Euro zone inflation smashes through ECB target to 2.5% in March as energy costs soar

Natural gas burners on a gas stove are seen in Rzeszow, Poland, on December 28, 2025. Nurphoto | Nurphoto | Getty Images Inflation in the euro zone jumped to 2.5% in March, according to the latest preliminary figures from Eurostat on Tuesday. Euro zone inflation was up from 1.9% in February and jumped well ahead […]

Read More